GlaxoSmithKline (GSK) was downgraded to a Hold Rating at Jefferies
In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...
Yahoo Finance1h
Health Canada approves GSK’s Ojjaara for myelofibrosis in anaemia patients
Health Canada has granted approval for GlaxoSmithKline’s (GSK) Ojjaara (momelotinib) for treating myelofibrosis (MF) in ...
A visit to Three Mile Island, where Constellation Energy hopes to restart a nuclear power plant
Constellation Energy is preparing to restart what's now called the Crane Clean Energy Center on Three Mile Island to supply ...
GlaxoSmithKline (GSK) Receives a Buy from Bernstein
Bernstein analyst Justin Smith maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...
Meet the Finalists: American Lawyer Litigator of the Year
The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...
JD Supra20d
GlaxoSmithKline and Northwestern Sue Moderna for Patent Infringement in Trio of Lawsuits
On October 15, 2024, GSK filed two complaints against Moderna in the District Court for the District of Delaware, asserting that Moderna willfully infringes GSK’s mRNA patent portfolio. In Civil ...
GlaxoSmithKline Pharmaceuticals Q2 net profit rises 16% to Rs 252 crore
Revenue from operations rose to Rs 1,010 crore for the September quarter compared with Rs 957 crore in the year-ago period, ...
devdiscourse15d
GlaxoSmithKline's Strong Quarterly Profit Growth and Special Dividend Declaration
GlaxoSmithKline Pharmaceuticals reported a notable 16% rise in consolidated net profit for the September quarter, reaching Rs 252 crore. This growth was driven by robust sales and brand performance.
GlaxoSmithKline Consolidated September 2024 Net Sales at Rs 1,010.77 crore, up 5.62% Y-o-Y
Other Operating Income------Total Income From Operations: 1,010.77: 814.65: 956.99: EXPENDITURE ...
India's GlaxoSmithKline Pharma posts higher Q2 profit on strong demand
India's GlaxoSmithKline Pharmaceuticals reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and vaccines.
money.rediff15d
GlaxoSmithKline Q2 Profit Rises 16% to Rs 252 cr
GlaxoSmithKline Pharmaceuticals reports a 16% jump in Q2 net profit to Rs 252 crore, driven by strong sales across segments.
Investing1d
GlaxoSmithKline Pakistan Ltd (GLAX)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...